AI-Powered Drug Discovery Market Forecast to 2032 Amid Biotech Boom and Precision Medicine Surge
The integration of Artificial Intelligence (AI) in drug discovery is reshaping the pharmaceutical and biotechnology industries. As we look toward 2032, the AI in drug discovery market is poised for significant expansion, driven by technological advancements, increasing demand for precision medicine, and the pressing need to streamline the drug development process. Market Size and Forecast to 2032 The AI in drug discovery market was valued at USD 1850.26 Million in 2024 to USD 14725.63 Million by 2032, growing at a CAGR of 29.6% during the forecast period (2025-2032). This expansion is fueled by the escalating cost and complexity of traditional drug discovery methods, which often span over a decade and require investments in the billions. AI promises to reduce both time and cost, making it an increasingly attractive solution for pharmaceutical companies and research institutions. Get a Free Sample Report - https://www.skyquestt.com/sample-request/ai-in-drug-discovery-market N...